# A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis

> **NCT04808843** · — · COMPLETED · sponsor: **Bayer** · enrollment: 160 (actual)

## Conditions studied

- Endometriosis Associated Pelvic Pain

## Interventions

- **DRUG:** Dienogest (BAY86-5258, Visanne)

## Key facts

- **NCT ID:** NCT04808843
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-13
- **Primary completion:** 2024-02-05
- **Final completion:** 2024-09-23
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808843, "A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04808843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*